These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


249 related items for PubMed ID: 11416985

  • 1. Thrombotic thrombocytopenic purpura--a syndrome caused by multiple pathogenetic mechanisms.
    Lian EC.
    Invest Clin; 2001 May; 42 Suppl 1():75-86. PubMed ID: 11416985
    [Abstract] [Full Text] [Related]

  • 2. Thrombotic thrombocytopenic purpura and the haemolytic-uraemic syndrome: evolving concepts of pathogenesis and therapy.
    Byrnes JJ, Moake JL.
    Clin Haematol; 1986 May; 15(2):413-42. PubMed ID: 3524932
    [Abstract] [Full Text] [Related]

  • 3. Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond.
    Lian EC.
    Semin Thromb Hemost; 2005 Dec; 31(6):625-32. PubMed ID: 16388413
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pathophysiology and treatment of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS).
    Kakishita E.
    Int J Hematol; 2000 Jun; 71(4):320-7. PubMed ID: 10905050
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.
    Lian EC, Mui PT, Siddiqui FA, Chiu AY, Chiu LL.
    J Clin Invest; 1984 Feb; 73(2):548-55. PubMed ID: 6538207
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The aptamer ARC1779 blocks von Willebrand factor-dependent platelet function in patients with thrombotic thrombocytopenic purpura ex vivo.
    Mayr FB, Knöbl P, Jilma B, Siller-Matula JM, Wagner PG, Schaub RG, Gilbert JC, Jilma-Stohlawetz P.
    Transfusion; 2010 May; 50(5):1079-87. PubMed ID: 20070617
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM, Rice L, Sarode R, Chow TW, Moake JL.
    Ann Intern Med; 2000 May 16; 132(10):794-9. PubMed ID: 10819702
    [Abstract] [Full Text] [Related]

  • 17. Thrombotic thrombocytopenia purpura (TTP) and other thrombotic microangiopathies.
    Moake J.
    Best Pract Res Clin Haematol; 2009 Dec 16; 22(4):567-76. PubMed ID: 19959109
    [Abstract] [Full Text] [Related]

  • 18. Thrombotic thrombocytopenic purpura.
    Moake JL.
    Thromb Haemost; 1995 Jul 16; 74(1):240-5. PubMed ID: 8578465
    [Abstract] [Full Text] [Related]

  • 19. Enhanced platelet adhesion and aggregation by endothelial cell-derived unusually large multimers of von Willebrand factor.
    Kumar RA, Moake JL, Nolasco L, Bergeron AL, Sun C, Dong JF, McIntire LV.
    Biorheology; 2006 Jul 16; 43(5):681-91. PubMed ID: 17047284
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.